Skip to main content
February 28

February 28, 2017
London, UK

Credit Suisse – One-on-One Healthcare Conference

March 14

March 14, 2017
Paris, France

Exane BNP Paribas – 19th Healthcare Conference

March 16

March 16, 2017
Miami, USA

Barclays – Global Healthcare Conference

March 30

March 30, 2017
Baden-Baden, Germany

Bankhaus Lampe – Deutschlandkonferenz

March 01

March 01, 2017
Boston, USA

Roadshow Boston

February 28

February 28, 2017
New York, USA

Roadshow New York

February 24

February 24, 2017
Frankfurt, Germany

Roadshow Frankfurt

February 27

February 27, 2017
London, UK

Morgan Stanley – European MedTech & Services Conference

Fresenius Helios closed its €5.76 billion acquisition of IDC Salud Holding S.L.U. (”Quirónsalud”) today, as planned. Quirónsalud will be consolidated as of February 1, 2017.

Of the total purchase price for Spain’s largest private hospital operator, €5.36 billion had already been debt-financed. The balance of €400 million was paid in the form of 6,108,176 new Fresenius shares issued today from authorized capital excluding subscription rights.

 

Quirónsalud’s network is comprised of 43 hospitals, 39 outpatient centers and about 300 Occupational Risk Prevention centers located in all economically important areas of Spain. The company has about 35,000 employees and offers the full spectrum of inpatient and outpatient care. With the acquisition, Fresenius Helios strengthens its position as Europe’s largest private hospital operator.

This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.

Fresenius Helios closed its €5.76 billion acquisition of IDC Salud Holding S.L.U. (”Quirónsalud”) today, as planned. Quirónsalud will be consolidated as of February 1, 2017.

Of the total purchase price for Spain’s largest private hospital operator, €5.36 billion had already been debt-financed. The balance of €400 million was paid in the form of 6,108,176 new Fresenius shares issued today from authorized capital excluding subscription rights.

Quirónsalud’s network is comprised of 43 hospitals, 39 outpatient centers and about 300 Occupational Risk Prevention centers located in all economically important areas of Spain. The company has about 35,000 employees and offers the full spectrum of inpatient and outpatient care. With the acquisition, Fresenius Helios strengthens its position as Europe’s largest private hospital operator.

This release contains forward-looking statements that are subject to various risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to certain factors, e.g. changes in business, economic and competitive conditions, regulatory reforms, results of clinical trials, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. Fresenius does not undertake any responsibility to update the forward-looking statements in this release.

Subscribe to